Physical Activity Pathway for Patients With Osteoarthritis in Primary Care (OA-PCP) (R33)
Key facts
- Who runs it
- University of North Carolina, Chapel Hill
- Where
- Chapel Hill, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 240 people enrolled
- Started
- 30 Nov 2020
- Ended
- 4 Dec 2023
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- OA-PCP Intervention
- Attention Control
- Record updated
- 24 October 2024
Who can take part
- Age
- 65 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 22 criteriaShow less
Who can take part
- Age 65 or older
- One other chronic health condition that qualified under Chronic Care Management (CCM) guidelines, including: diabetes, depression, hypertension, hyperlipidemia, heart failure, atrial fibrillation, ischemic heart disease, stroke/transient ischemic attack (TIA), peripheral vascular disease, Chronic obstructive pulmonary disease (COPD), bronchiectasis, asthma, rheumatoid arthritis, osteoarthritis, HIV/AIDS, chronic kidney disease, hepatitis (chronic \& viral B \& C) and osteoporosis
- Current Joint Symptoms
- Self-reported physical activity <150 minutes per week
- Willing to make a change in PA over the next 3 months
Who cannot take part
- Total knee or hip replacement surgery, meniscus tear, ligament tear, or other significant lower extremity injury or surgery in the last 6 months
- Unstable chronic obstructive pulmonary disease (2 hospitalizations within the previous 6 months and/or on oxygen)
- Dementia or other memory loss condition
- Active Substance abuse disorder
- Severe hearing or visual impairment
- Serious/terminal illness as indicated by referral to hospice or palliative care
- Unstable angina
- History of ventricular tachycardia
- Stroke with moderate to severe aphasia
- Pain in chest when performing physical activity
- Pain in chest when not performing physical activity
- Loss of balance because of dizziness or loss of consciousness
- Recommendation from doctor to only perform physical activity under medical supervision
- No documented diagnosis of knee or hip OA
- Active diagnosis of psychosis
- Hospitalization for cardiovascular event in last 6 months
- Recent history (last 6 months) of three or more falls
Where in United States
- UNC Thurston Arthritis Research CenterChapel Hill, United States
About the trial
What the trial wants to find out
The purpose of this study is to test an osteoarthritis (OA) primary care Physical activity Care Pathway (OA-PCP), a scalable intervention that includes: 1) a practical process for physical inactivity screening in primary care, 2) a brief, tailored physical activity (PA) counseling intervention via telephone, 3) connection of patients with community programs and other resources to support PA, and 4) follow-up with patients to deliver additional appropriate counseling and referrals to PA resources. This program will be compared to another program that provides education on a variety of topics important to understanding osteoarthritis (OA) and its care.
The 2 groups in the trial
- OA-PCPTreatment being tested
Participants assigned to the OA-PCP intervention will receive an initial physical activity (PA) coaching call then, 5 more calls over the course of 12 months. Participants, if they agree, will also receive monthly check-in emails between phone calls.
Treatment: OA-PCP Intervention
- Attention ControlPlacebo, for comparison
Participants assigned to the Attention Control group will receive the same number of phone calls over the course of 12 months, focused on understanding osteoarthritis (OA) and current information on treatment options. Participants, if they agree, will also receive monthly check-in emails between phone calls.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Physical Activity Pathway for Patients With Osteoarthritis in Primary Care
- Record updated
- 24 October 2024